Glipizide ER (extended release) is a medication used to treat type 2 diabetes. It is a sulfonylurea drug, which works by stimulating the pancreas to produce more insulin. It is a long-acting form of glipizide, which is a generic drug. Glipizide ER is a once-daily medication that helps to control blood sugar levels. It is often used in combination with other diabetes medications, such as metformin or insulin. The aim of this article is to provide a comprehensive review of glipizide ER, including its effectiveness, side effects, and safety.
Glipizide ER is an extended-release form of glipizide, a generic drug. It works by stimulating the pancreas to produce more insulin. Insulin is a hormone that helps the body use glucose from carbohydrates in the food we eat for energy or to store glucose for future use. Glipizide ER is usually taken once daily, usually in the morning. It is usually taken with food to reduce the risk of low blood sugar.
Studies have shown that glipizide ER is effective in controlling blood sugar levels in people with type 2 diabetes. In a 12-week study of over 400 people with type 2 diabetes, glipizide ER was found to be more effective than placebo in reducing fasting blood glucose levels. In another study of over 500 people with type 2 diabetes, glipizide ER was found to be more effective than placebo in reducing HbA1c levels.
Like all medications, glipizide ER can cause side effects. Common side effects include nausea, headache, dizziness, and diarrhea. Less common side effects include skin rash, weight gain, and abdominal pain. Rare side effects include low blood sugar (hypoglycemia) and an allergic reaction.
Glipizide ER is generally safe when taken as directed. It is important to follow the instructions of your healthcare provider when taking this medication. It is also important to monitor your blood sugar levels regularly and to report any changes to your healthcare provider.
In conclusion, glipizide ER is an effective medication for controlling blood sugar levels in people with type 2 diabetes. It is usually taken once daily and is usually taken with food to reduce the risk of low blood sugar. Common side effects include nausea, headache, dizziness, and diarrhea. It is important to follow the instructions of your healthcare provider and to monitor your blood sugar levels regularly.
1.
Mammo Responsibility Increases Screening; Opioids for Pain Related to Cancer? Ignored CRC Signs.
2.
Study confirms safety and efficacy of higher-dose-per-day radiation for early-stage prostate cancer
3.
Access to GLP-1 medications associated with a lower risk of colorectal cancer in people with type 2 diabetes: JAMA.
4.
A garden can save your life
5.
Effective Intralesional Melanoma Therapy May Involve Systemic Effects.
1.
Precision Oncology Advances: Neoantigen Therapies, TCR Strategies & Radiotherapy Innovations
2.
Navigating the Evolving Landscape of Oncology Clinical Trials in the Era of Precision Medicine
3.
Building Physical Resilience in Chronic Blood Disorders
4.
Advanced Approaches in Oncology and Patient Outcomes
5.
Thyroid Cancer and Insulin Resistance: Unraveling the Complex Interplay for Better Patient Outcomes
1.
International Conference on Innovations in Critical Care for Oncology and Cardiology
2.
International Conference on Oncology, Cardiology and Critical Care Policy
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
1.
Common side effects of cancer treatment and how they are managed
2.
Case-Based Learning: Oncology
3.
Dissecting Molecular differences between EGFR Exon 19 deletion and Exon 21 L858R Mutations
4.
Daratumumab, Lenalidomide, and Dexamethasone (DRd) Versus Lenalidomide and Dexamethasone (Rd) in MRD Negativity
5.
Understanding the Importance of Follow-Up After Cancer Treatment
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation